đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this Phase 3, observer-blind, placebo-controlled, multi-cent...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-23
Trial ID
NCT00616928
Treatments Being Tested
Evaluate the safety and immunogenicity of four different doses of H7N9 vacc...
Status
Completed
Location
Site 04: Accelovance
Start Date
2013-08
Trial ID
NCT01928472
Today, the leading contender for the next pandemic of influenza is H5N1, a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03-29
Trial ID
NCT00309647
The present study, phase III, randomized, controlled, observer-blind, multi...
Status
Completed
Location
Tampere Vaccine Research Clinic (15 sites)
Start Date
2008-10
Trial ID
NCT00841763
The main purpose of this study is to assess the ability of H5 influenza vir...
Status
Completed
Location
Optimal Research
Start Date
2018-03-15
Trial ID
NCT03497845
Treatments Being Tested
This study will assess safety and immunogenicity of GSK Biologicals' H5N1 f...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-03-07
Trial ID
NCT01310413
Treatments Being Tested
This study aims to demonstrate the safety and immunogenicity of two formula...
Status
Recruiting
Location
Centro de Terapias Avançadas E Inovadoras - Ct Terapias/Ufmg
Start Date
2025-09-10
Trial ID
NCT06842173
This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2018-02-20
Trial ID
NCT03318315
Today, the leading contender for the next pandemic of influenza is H5N1, a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05-01
Trial ID
NCT00319098
Treatments Being Tested
This trial will assess the immunogenicity and safety of GSK Biologicals' va...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-08-12
Trial ID
NCT01416571
Treatments Being Tested